Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2005 02:13 ET | Source: Crucell N.V.

Crucell and DSM Announce PER.C6(R) Licensing and Service Agreement with Roche for Protein Production

LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that they...
February 16, 2005 02:11 ET | Source: Crucell N.V.

Crucell Receives Patents Covering PER.C6(R) for Protein Production

LEIDEN, The Netherlands, Feb. 16, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted two pivotal patents relating to...
January 31, 2005 08:05 ET | Source: Crucell N.V.

Crucell Confirms Selection for Amsterdam Midkap Index on Euronext

LEIDEN, The Netherlands, Jan. 31, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that its inclusion in the Amsterdam Midkap (AMX) index...
January 26, 2005 07:38 ET | Source: Crucell N.V.

Crucell Fully Compliant

LEIDEN, The Netherlands, Jan. 26, 2005 (PRIMEZONE) -- In media coverage today a suggestion was made that insider trading occurred on the exercise of options on January 18, 2005, by certain employees...
January 24, 2005 09:01 ET | Source: Crucell N.V.

Crucell Announces 2004 Annual Results

LEIDEN, Netherlands, Jan. 24, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Nasdaq:CRXL) (Euronext:CRXL) today announced its 2004 financial results. Revenue for the year ended...
January 20, 2005 02:08 ET | Source: Crucell N.V.

Boehringer Ingelheim Licenses Results from Target Discovery Collaboration with Galapagos

LEIDEN, The Netherlands and MECHELEN, Belgium, Jan. 20, 2005 (PRIMEZONE) --Galapagos announced today that Boehringer Ingelheim has successfully used Galapagos' SilenceSelect(tm) gene knock-down...
January 14, 2005 02:08 ET | Source: Crucell N.V.

Crucell Joins Influenza Vaccine Supply (IVS) International Task Force

LEIDEN, The Netherlands, Jan. 14, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been accepted as a new member of the Influenza...
January 10, 2005 08:08 ET | Source: Crucell N.V.

Crucell to Release 2004 Earnings on Monday, January 24, 2005

LEIDEN, Netherlands, Jan. 10, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) today announced that it will release its full year 2004 financial results on...
January 07, 2005 02:08 ET | Source: Crucell N.V.

Crucell Announces Evaluation by Genentech of STAR(TM) Technology

LEIDEN, The Netherlands, Jan. 7, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that Genentech, Inc. (NYSE:DNA) is currently evaluating...
January 05, 2005 02:07 ET | Source: Crucell N.V.

Crucell Receives European Patent Covering PER.C6(R) for Vaccine Production

LEIDEN, The Netherlands, Jan. 5, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has been granted a patent by the European Patent...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right